In the 2017 CPhI Annual Report , Dilip G. Shah, CEO of Vision Consulting Group and secretary general, Indian Pharmaceutical Alliance, discusses the ongoing tension between competition and exclusivity and the impact on access to medicines. He notes that competition supports multi-source supplyOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.